Back EDQM releases guidance on paper and board materials and articles for food contact

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published the first edition of the technical guide entitled “Paper and board used in food contact materials and articles”, following the October 2020 adoption of the resolution on the safety and quality of materials and articles for contact with food by the Committee of Ministers of the Council of Europe.
EDQM Strasbourg, France 19/05/2021
  • Diminuer la taille du texte
  • Augmenter la taille du texte
  • Imprimer la page
  • Imprimer en PDF
EDQM releases guidance on paper and board materials and articles for food contact

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published the first edition of the technical guide entitled “Paper and board used in food contact materials and articles”, following the October 2020 adoption of the resolution on the safety and quality of materials and articles for contact with food1 by the Committee of Ministers of the Council of Europe.2

This publication incorporates the resolution and its guiding principles and provides technical guidance relating to the requirements, compliance testing and supporting documentation for paper and board materials. It was drafted by the European Committee for Food Contact Materials and Articles (CD-P-MCA) and was subject to a public stakeholder consultation in 2020.

This guidance document is expected to improve the protection of consumers against contaminants (metals, antioxidants, stabilisers, colorants, plasticisers, etc.) potentially released by materials in contact with food (packaging, containers, plates, cups, straws, baking and filter papers, napkins, etc.). It also aims to support the harmonisation of regulatory approaches to consumer health protection across Europe.

The publication can be downloaded for FREE from the EDQM Freepub website.

See also:


[2]. In its composition restricted to representatives of the States Parties to the Convention on the Elaboration of a European Pharmacopoeia: Albania, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Republic of Moldova, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Romania, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Republic of Türkiye, Ukraine and United Kingdom.